SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-12-457568
Filing Date
2012-11-07
Accepted
2012-11-07 16:36:04
Documents
9
Effectiveness Date
2012-11-07

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR d433544ds3asr.htm S-3ASR 579635
2 FORM OF INDENTURE d433544dex47.htm EX-4.7 295506
3 OPINION OF WHITE SUMMERS CAFFEE & JAMES, LLP d433544dex51.htm EX-5.1 19335
4 OPINION OF LATHAM & WATKINS LLP d433544dex52.htm EX-5.2 22884
5 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES d433544dex121.htm EX-12.1 44368
6 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED ACCOUNTING FIRM d433544dex231.htm EX-23.1 2208
7 GRAPHIC g433544g12q75.jpg GRAPHIC 1869
8 GRAPHIC g433544g73o18.jpg GRAPHIC 8394
9 GRAPHIC g433544g93q13.jpg GRAPHIC 2929
  Complete submission text file 0001193125-12-457568.txt   983875
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-184807 | Film No.: 121187251
SIC: 2834 Pharmaceutical Preparations